Toronto Dominion Bank’s Centessa Pharmaceuticals CNTA Stock Holding History

Toronto Dominion Bank’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-654,850	Closed	-$26M	–	2334
2026 Q1	$26M	Buy	+654,850	New	+$16.7M	0.04%	352

Toronto Dominion Bank's CNTA Position: Q2 2026 in Review

Toronto Dominion Bank sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 654,850 shares — an estimated $26M sold.

Toronto Dominion Bank first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $26M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Toronto Dominion Bank reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Toronto Dominion Bank sold 654,850 Centessa Pharmaceuticals shares in Q2 2026, an estimated $26M.
Toronto Dominion Bank first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Toronto Dominion Bank's Centessa Pharmaceuticals position peaked at $26M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.